Rutin as A Novel c-Met Inhibitory Lead for The Control of Triple Negative Breast Malignancies

Triple negative breast cancer (TNBC) has high metastatic and mortality potential and lacks effective and selective therapeutic options. Aberrant dysregulation of the receptor tyrosine kinase c-Met promotes TNBC progression, motility and survival and therefore considered a valid therapeutic target. A...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nutr Cancer
Principais autores: Elsayed, Heba E., Ebrahim, Hassan Y., Mohyeldin, Mohamed M., Siddique, Abu Bakar, Kamal, Amel M., Haggag, Eman G., El Sayed, Khalid A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6193555/
https://ncbi.nlm.nih.gov/pubmed/29083228
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/01635581.2017.1367936
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados